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Abstract
Introduction: According to updated evidence-based national recommendations which have been published recently vitamin D 
deficiency remains still highly prevalent in Poland and requires supplementation. 
Aim of the study was to evaluate the effectiveness of implementation of the new national recommendations into daily practice. 
Material and methods: An analysis of medical records of 100 children aged from 6 months to 14 years admitted to the Department 
of Pediatrics, Hospital in Brzesko, Lesser Poland, from 1st July 2018 to 31st August 2018. 
Results: 41% patients declared vitamin D supplementation. Among patients under 1 year of age 3 (60%) received recommended 
supplementation of 400-600 IU daily, in the group of 1-11 years old 15 (19.5%) used a 600-1000 IU dose daily, 13 (17%) < 600 IU/
daily, and 2 (2.5%) > 1000 IU daily, 1 patient did not remember the dose. In the group >11 years of age 6 (37.5%) supplemented 
800-2000 IU/day, 1 (6.3%) less than 800 IU, no one overdosed supplementation. In the group without supplementation, there were 
3 patients with a decreased 25(OH)D blood serum level (< 20 ng/ml). Mean 25(OH)D serum level was significantly higher in the group 
with vitamin D supplementation (42 vs. 33.9 ng/ml; p = 0.0006). There was no significant difference between mean 25(OH)D level in 
patients receiving adequate (40.5 ng/ml), to low (43 ng/ml), or to high vitamin D doses (49 ng/ml). There was no significant correlation 
between vitamin D dose and the 25(OH)D serum level [R = (–) 0.24, p > 0.05)]. 
Conclusions: There is an urgent need for physicians to provide an education concerning general rules of vitamin D supplementation, 
because the present guidelines of the vitamin D supplementation are not implemented well enough. 
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Streszczenie
Wprowadzenie: Zgodnie z opublikowanymi ostatnio polskimi, opartymi na dowodach naukowych, zaleceniami niedobór witaminy D 
występuje powszechnie i konieczna jest jej suplementacja.
Cel pracy: Realizacja nowych polskich zaleceń w codziennej praktyce. 
Materia i metody: Analizie poddano dokumentację medyczną 100 pacjentów w wieku od 6 miesięcy do 14 lat hospitalizowanych 
na Oddziale Dziecięcym Szpitala w Brzesku w Małopolsce w okresie od 1 lipca 2018 r. do 31 sierpnia 2018 r. 
Wyniki: Suplementację witaminy D zadeklarowało 41% pacjentów. Wśród pacjentów poniżej 1. roku życia 3 (60%) otrzymywało 
rekomendowaną dawkę suplementacyjną, tj. 400–600 IU dziennie. W grupie 1–11 lat 15 pacjentów (19,5%) stosowało rekomendo-
waną dawkę 600–1000 IU dziennie, 13 (17%) < 600 IU dziennie i 2 (2,5%) > 1000 IU dziennie, w przypadku 1 pacjenta nie udało 
się ustalić dawki. W grupie > 11 lat 6 pacjentów (37,5%) stosowało dawkę 800–2000 IU dziennie, 1 (6,3%) mniej niż 800 IU, nikt 
nie stosował dawki większej niż rekomendowana. U 3 osób spośród niestosujących suplementacji stwierdzono zmniejszone stężenie 
25(OH)D w surowicy krwi (< 20 ng/ml). Średnie stężenie 25(OH)D w surowicy był istotnie większe w grupie stosującej suplementację 
(42 vs 33,9 ng/ml; p = 0,0006). Nie stwierdzono natomiast istotnej różnicy między średnim stężeniem 25(OH)D u pacjentów otrzy-
mujących dawkę rekomendowaną (40,5 ng/ml), w porównaniu z przyjmującymi mniejszą (43 ng/ml) lub większą (49 ng/ml) dawkę niż 
zalecana. Nie stwierdzono istotnej korelacji między dawką witaminy D a stężeniem 25(OH)D w surowicy [R = (–) 0,24; p > 0,05)].
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Wnioski: Istnieje pilna potrzeba wprowadzenia właściwej edukacji pacjentów w zakresie zasad suplementacji witaminy D na pozio-
mie podstawowej opieki zdrowotnej, ponieważ obecnie codzienna praktyka znacząco odbiega od zaleceń ekspertów.
Słowa kluczowe: 
witamina D, dzieci.
Introduction
The problem of vitamin D deficiency has been one of the most 
frequently emerging topics in medical literature in recent years. 
Historically, vitamin D was connected with the recognition of 
a new childhood bone disease named rickets by Francis Glisson 
in 1650 [1]. The first report linking rickets with lack of sunlight was 
published by Śniadecki in 1822, and soon liver cod oil became 
an antirachitic medication [1]. It seemed to be the first model of 
vitamin D supplementation, although the process of transforma-
tion of 7-dehydrocholesterol via ultra-violet irradiation in the skin 
was discovered a hundred years later [2]. These discoveries, and 
subsequent food fortification with vitamin D reduced significant-
ly rickets incidence rate in Europe and North America [1, 3]. In 
recent years, an active form of vitamin D [calcitriol, 1,25-dihy-
droxycholecalciferol (1,25(OH)2D)], has proved not only to be an 
important element of calcium level regulation, but also a hormone 
with a huge impact on the functioning of the entire body. Calcitriol 
acts as a transcription factor but it also impacts on many tissues in 
a “non classical way” using nuclear (VDR) and membrane recep-
tors (MARRS), and regulates cellular proliferation and apoptosis. 
[2,  4-6]. Many studies showed that vitamin deficiency may be 
associated with an increased risk of cancer, diabetes, cardio-pul-
monary diseases, metabolic and autoimmune disorders and even 
infections and mental illness [2]. This information became more 
significant, considering that vitamin D deficiency can affect as 
many as 70% of adults, children and adolescents in Poland [7, 8] 
Therefore, vitamin D supplementation has become an important 
issue in public health. Consequently, many recommendations 
concerning supplementation have been published over the recent 
years by the scientific society all over the world. Recently, new 
and updated guidelines were published in 2018 for the general 
population in Poland and for groups at risk of vitamin D deficien-
cy. It has been generally recommended that prophylactic dosing 
of vitamin D in the general population should be individualized 
depending on age, body weight, isolation (season, time of year), 
sun exposure of an individual, dietary habits and lifestyle. For 
healthy neonates and infants (0-6 months): 400 IU/day from the 
first days of life, regardless of the method of feeding. For infants 
6-12 months: 400-600 IU/day, depending on the daily amount of 
vitamin D taken with food. For children (1-10 years) 600-1000 IU/
day, and for adolescents (11-18 years) 800-2000 IU/day based on 
body weight and the dietary vitamin D intake, except for healthy 
children and adolescents sunbathing with uncovered forearms and 
legs for at least 15 min between 10.00 a.m. and 3 p.m., without 
sunscreen, in the period from May to September. In this last group, 
supplementation is not necessary, although still recommended and 
safe [5, 9, 10]. In order to evaluate patients’ vitamin D status, the 
guidelines recommend using the serum 25(OH)D level [11, 12]. 
According to the present guidelines, the optimal level of 25(OH)D 
is defined as 30-50 ng/ml. Deficiency is a clinical syndrome de-
fined as a 25(OH)D serum level < 20 ng/ml, and insufficiency as 
a 21-29 ng/ml. Both of these clinical statuses are recommended 
for 25(OH)D treatment or supplementation, respectively [4, 5]. 
The aim of the present study was to evaluate the effective-
ness of implementation of these new national recommendations 
into daily practice on the example of one paediatric centre.
Material and methods
This retrospective analysis included the medical records of 
100 children aged from 6 months to 14 years admitted to the De-
partment of Pediatrics, Hospital in Brzesko, Lesser Poland, from 
1st July 2018 to 31st August 2018. All analyzed patients were living 
in the district of Brzesko which, according to the Central Statistical 
Office data, has 15 325 inhabitants under 14 years old. The ana-
lyzed probe contained 0.6% of the total population. No one was 
admitted due to vitamin D deficiency, nor calcium-phosphorus 
metabolism disorders. Most of the patients were admitted due 
to respiratory and gastrointestinal infections or the suspicion of 
allergy. Calcium, phosphorus and 25(OH)D levels in blood were 
measured on admission, using the immunochemistry method 
(ECLIA) with a Cobas e411 machine (Roche Diagnostics GmbH, 
Mannheim, Germany). Data from the patients’ medical history 
included: date of birth, date of hospital admission, presence of 
concomitant chronic diseases and medications, 25(OH)D serum 
level, vitamin D supplementation details: dose and form. Based 
on reported data, children were classified into two main groups: 
with and without supplementation of vitamin D. Additional sub-
analyses considering dosage and the type of preparation used 
were performed as well. To compare two sets of data, the t-Stu-
dent test was employed for independent samples, and in case of 
absence of normal data distribution – a two-sided Mann-Whitney 
U test. To compare more than two groups, the variance analysis 
and post hoc tests were used. 
Spearman’s Rank-Order Correlation was used to measure the 
strength of association between pairs of variables. Calculations 
were performed using the STATISTICA 13 software.
Results 
Even though the study included summer months (July and 
August) only, in which according to the guidelines, supplementa-
tion is not necessary except the first year of life, 41/100 (41%) of 
patients received vitamin D. Fourteen of them used medications: 
5  used a  prescription drug, and 9 an over-the-counter (OTC) 
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drug; 11 used various diet supplements containing vitamin D only, 
7 complex diet supplements, 1 patient used a medication not reg-
istered in Poland, 8 did not remember the drug’s name and dose 
(Fig. 1). The group included 3/5 (60%) patients under 1 year with 
the recommended supplementation of 400-600 IU daily. In the 
older group of patients between 1-11 years, 15/76 (19.5%) used 
a dose of 600-1000 IU daily, 13/76 (17%) < 600 IU/daily, and 2/76 
(2.5%) > 1000 IU daily, 1/76 patient did not remember the dose. 
In the adolescents over > 11 years 6/16 (37.5%) supplemented 
800-2000IU/day, 1/16 (6.3%) less than 800 IU, no one overdosed 
supplementation (Fig. 2). In the group of patients with deceler-
ated 25(OH)D supplementation, there was no case of with vita-
min D deficiency defined as a 25(OH)D serum level < 20 ng/ml. 
In the group without supplementation, there were 3 patients with 
decreased vitamin D blood serum level, but clinically asymptom-
atic. There was no significant difference between mean 25(OH)D 
level in patients receiving drugs or medical supplements (41.6 vs. 
43.7 ng/ml; p > 0.05). There was no significant difference be-
tween mean 25(OH)D level in patients receiving drugs and diet 
supplements (Fig. 3). There was no significant difference between 
mean 25(OH)D level in patients receiving adequate (40.5 ng/ml), 
to low (43 ng/ml), or to high vitamin D doses (49 ng/ml) (Fig. 4). 
Figure 1. Structure of the types of preparations used contain-
ing vitamin D
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Figure 2. Vitamin D supplementation in the studied group in 
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Figure 3. Comparison of the 25(OH)D levels between patients 
using drugs and diet supplements. The difference was not 
statistically significant (p > 0.05)
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Figure 4. Comparison of the 25(OH)D levels between patients 
using different doses of vitamin D. The difference was not sta-
tistically significant (p > 0.05)
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There was no significant correlation between the supplement-
ed vitamin D dose, and 25(OH)D serum level [R = (–) 0.24, 
p > 0.05)]. Mean 25(OH)D serum level was significantly higher in 
the group of children with declared vitamin D supplementation 
(42 vs. 33.9 ng/ml; p = 0.0006) (Fig. 4).
Discussion
Vitamin D is a  group of fat-soluble steroids responsible for 
intestinal absorption and skeletal mobilization of calcium, mag-
nesium, and phosphate. In addition to this classic role, vitamin D 
and its metabolites also have pleiotropic effects, as evidenced by 
numerous studies published in recent years [1, 4]. The main two 
forms of Vitamin D are cholecalciferol (D3) and the less potent 
ergocalciferol (D2). Cholecalciferol can be synthesized in the skin 
through a reaction dependent on UV radiation. This natural skin 
production in exposure to sunlight remains the major source of 
25(OH)D. However, skin synthesis is affected by such factors as: 
geographic region, season of the year, day time, air pollution, 
exposed skin area and skin tone [1, 10, 13]. Another important 
limitation is also the use of sunscreen (SPF over 15) that reduces 
natural vitamin D skin synthesis to 1-5%. Sedentary life style and 
limitation of natural physical activity outside is even more prob-
lematic. According to the statistics, a quarter of children in the Eu-
ropean Union lead a sedentary lifestyle, spend more time indoors 
and have an unhealthy diet [5, 13]. Both (D3 and D2) can be also 
ingested from the diet and from supplements [7, 8, 10]. Because 
only few foods naturally contain vitamin D, fish and fish liver oil 
became the main food 25(OH)D source [4]. It is estimated that 
a balanced, healthy diet can cover no more than 20% of the daily 
vitamin D demand. The UK Food Standards Agency assay that 
daily food vitamin D intake is less effective that sunlight related 
skin synthesis [14, 15]. Łupińska assessed factors afering serum 
vitamin D status in schoolchildren from Łodź and noted that food 
with high vitamin D concentration has no significant influence 
on serum 25(OH)D level. What is more, according to common 
vitamin D insufficiency in diet only 5% children had optimal daily 
vitamin D intake [16]. Therefore, some countries (ex. USA and 
Canada) already fortify daily food products such as bread, cere-
als, yogurts and cheese with vitamin D, while in Europe some 
Scandinavian countries fortify milk [4]. Unfortunately these actions 
seem to remain insufficient, because as it has been suggested in 
previously published papers the consumption of milk is decreas-
ing. Furthermore, children now spend less and less time outdoors. 
Thus, the skin synthesis of vitamin D is reduced [4]. A Scandina-
vian study assessed food fortification as an alternative for supple-
ments by milk-based vitamin D supplementation dose in order to 
gain sufficient 25(OH)D concentration in children with fair and 
dark skin in the southern and northern parts of Sweden. In that 
study, the daily intake of 6-20 µg/day (fair skin) and 14-28 µg/day 
(dark skin) was sufficient to maintain concentration 20 ng/ml [17]. 
Similar studies conducted in Denmark and in Canada emphasized 
the need for food fortification [18, 19]. Therefore, there is a need 
of additional vitamin D supplementation at the population level in 
developed countries [20-22]. In recent years, many guidelines and 
recommendations of vitamin D supplementation have been pub-
lished. Recent Polish guidelines by Rusińska et al. were published 
this year [4, 5, 7, 8]. Although recommendations are general and 
common in their nature, the knowledge and application at the 
population level seems to be insufficient as yet [11]. Our present 
study was dedicated to the assessment of the vitamin D supple-
mentation practices in one paediatric centre. We chose a sample 
of the local population (0.6%) for the analysis. The strength of 
such selection is the homogenous structure of the investigated 
group. All of the participants and their parents lived in the same, 
limited geographic area, and presented a similar socioeconomic 
status and educational level. Limitation of the duration time to the 
two summer months only allowed us to eliminate the potential 
impact of sun exposure on the 25(OH)D levels. The main weak-
ness of the study is the fact that the sample was not random, but 
selected from the patients admitted to the hospital, although we 
excluded participants with the presence or suspicion of calcium-
phosphorus disorders or treated with medications that may im-
pact on vitamin D metabolism. The results of the present study 
show that almost half of the participants received vitamin D con-
taining drugs or diet supplements. We did not identify any patient 
with vitamin D deficiency in the group receiving supplementa-
tion, but there were 3 individuals with 25(OH) D level < 20 ng/ml 
in the group without supplementation. However, patients did 
not demonstrate any symptoms of vitamin D deficiency this ob-
servation confirms that the use of vitamin D may be beneficial 
also during the summer, which has been clearly articulated in 
the new national recommendations. The former recommenda-
tions of vitamin D supplementation in the summer period not 
being necessary was based on the fact that exposure to sunlight 
allows skin synthesis from 7-dehydrocholesterol to previtamin D 
by a photochemical, non-enzimatic process using UVB lights with 
wavelengths between 270 and 300 nm, with a peak between 295 
and 297 nm. In a few hours, using thermal energy, previtamin D 
becomes cholecalciferol (vitamin D3), which is transported with 
proteins to the liver. The liver is the first step of vitamin D activa-
tion using 25-hydroxylase from cytochrome 450. The second step 
is the kidneys, where 25(OH)D under 1α-hydroxylase (CYP27B1) 
becomes 1,25-dihydroxycholecalciferol – calcitriol. 1,25(OH)D is 
the only active form of vitamin D [1, 4, 5]. Even though the mean 
level of 25(OH)D was significantly higher in patients receiving vi-
tamin D supplementation, there was no case of going over the 
limit of the range. That confirms that oral supplementation of vita-
min D is rather safe, even in case of use incompatible with what is 
recommended. Nevertheless, it is still interesting why patients are 
failing to comply with recommendations. Is it only a health-care 
professional issue? Some hint may be found in the analysis of the 
stricture of used preparations containing vitamin D. Only 5 par-
ticipants received a prescription drug, but only 1 under 1  year 
of age. The remaining group of 36 people declaring regular sup-
plementation used OTC drugs (no one < 1 year) or diet supple-
ments, one used a supplement which was not even registered in 
Poland. These results show clearly that vitamin D supplementation 
in the investigated group is not only incompatible with the pres-
ent guidelines, but probably out of control of the physicians. This 
seems to be a consequence of the fact, that vitamin D deficiency 
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prevention is not a medical problem any more, but a  life style 
issue as well. The awareness of vitamin D supplementation in 
parents in Poland seems to be sufficient. Nevertheless, the way 
it is conducted raises concern, which has been confirmed by the 
results of the present study. Therefore, it is necessary to put an 
emphasis on the education provided by physicians. There is a sig-
nificant role of primary care physician in the implementation of 
the guidelines in the population [2, 4, 11]. Also it would be worth 
considering conducting similar study assessing if realization recent 
guidelines may affect on patients compliance measured by reduc-
tion vitamin D deficiency in population in future years.
Conclusions
The present guidelines of the vitamin D supplementation are 
not implemented well enough. Oral supplementation of vitamin 
D with the daily dose of 200-2000 IU in children and adolescents 
even in the summer does not cause an increase of the 25(OH)D 
level above the upper limit of the range. There is an urgent need 
for education to be provided by physicians concerning general 
rules of vitamin D supplementation.
